相关实验视频

Updated: Jun 5, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

逐步选择的抗多克索鲁比抗性MCF-7细胞系的复制数变异

Hasan Huseyin Kazan¹, İrem Sinem Acınan², Başak Kandemir³

¹Department of Medical Biology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.

|December 5, 2024

概括

乳腺癌细胞中的多药耐药性 (MDR) 涉及复杂的遗传变化. DNA微阵列揭示了多克索鲁比抗性MCF-7细胞的显著拷贝数变异 (CNV),突出了它们在耐药性中的作用.

科学领域:

基因组学就是基因组学.
癌症生物学癌症生物学
分子瘤学分子瘤学

背景情况:

多药耐药性 (MDR) 是一种复杂的细胞表型,通过多种途径随着时间的推移而获得.
虽然在MDR中研究了基因表达,但细分和复制数变异 (CNVs) 的理解较少.
了解基因变异对于开发有效的癌症疗法至关重要.

研究的目的:

用DNA微阵列分析敏感和抗多克索鲁比的MCF-7乳腺癌细胞系中的副本数变异 (CNVs).
调查多克索鲁比抗性水平与基因组改变之间的关系.
识别与多药耐药性相关的潜在基因组标记物.

主要方法:

传统的型化和阵列比较基因组杂交 (aCGH) 在敏感的 (MCF-7) 和两个抗多克索鲁比的 (MCF-7/400DOX,MCF-7/1000DOX) 细胞系上进行.
aCGH数据经过了基因组分析,比较分析和异性分析.
将基因列表与乳腺癌和与多种药物耐药性相关的基因组进行了比较.

主要成果:

在细胞系之间观察到CNV概况和基因拷贝数量的显著差异.
改变基因的数量在MCF-7中为6212个,在MCF-7/400DOX中为6558个,在MCF-7/1000DOX中为11201个.
MCF-7/1000DOX表现出最多的基因变异,这表明抗性水平和染色体变化之间的相关性.

结论:

乳腺癌细胞中多克索鲁比耐药性与实质性和差异性染色体变化有关.
基因组微阵列分析是研究癌症药物耐药性机制以及转录组和蛋白组方法的宝贵工具.
识别CNV为多药耐药性的分子基础提供了洞察力,可能有助于治疗策略.

关键词:

癌症药物耐药性癌症药物耐药性副本数量的变化副本数量的变化这是一个DNA微阵列.型化 (Karyotyping) 是一种方法.

更多相关视频

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

相关概念视频

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...